SPONSOR
M2RLAB SL
Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Acute Kidney Injury
M2RLAB SL is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Acute Kidney Injury.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — M2RLAB SL
How many clinical trials has M2RLAB SL sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by M2RLAB SL, of which 1 are actively recruiting participants. These trials cover conditions including Acute Kidney Injury. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does M2RLAB SL research focus on?
M2RLAB SL clinical trials span Acute Kidney Injury. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a M2RLAB SL clinical trial?
To participate in a M2RLAB SL trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all M2RLAB SL trials with current recruitment status updated daily.
Clinical Trials by M2RLAB SL
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology